{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:28:30Z","timestamp":1789691310684,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T00:00:00Z","timestamp":1670630400000},"content-version":"vor","delay-in-days":5457,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1111\/j.1538-7836.2007.02772.x","type":"journal-article","created":{"date-parts":[[2007,9,24]],"date-time":"2007-09-24T07:18:26Z","timestamp":1190618306000},"page":"2-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"title":["Hypercoagulation and thrombophilia in liver disease"],"prefix":"10.1016","volume":"6","author":[{"given":"P.G.","family":"NORTHUP","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"SUNDARAM","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.B.","family":"FALLON","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.R.","family":"REDDY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.A.","family":"BALOGUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.J.","family":"SANYAL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q.M.","family":"ANSTEE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.R.","family":"HOFFMAN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"IKURA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.H.","family":"CALDWELL","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1111\/j.1538-7836.2007.02772.x_bb0010","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1097\/00001721-200004001-00014","article-title":"Coagulation problems in liver disease","volume":"11","author":"Rapaport","year":"2000","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0015","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0889-8588(18)30273-9","article-title":"Coagulation abnormalities in liver disease","volume":"6","author":"Mammen","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0020","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0025","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1440-1746.2000.02157.x","article-title":"Budd\u2013Chiari syndrome: our experience of 71 patients","volume":"15","author":"Singh","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0030","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/j.1572-0241.2006.00588.x","article-title":"Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism","volume":"101","author":"Northup","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0035","first-page":"96","article-title":"Prognostic value of clotting and fibrinolytic systems in a follow\u2010up of 165 liver cirrhotic patients. CALC Group","volume":"22","author":"Violi","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0140-6736(02)07282-3","article-title":"Interpretation of the international normalised ratio in patients with liver disease","volume":"359","author":"Deitcher","year":"2002","journal-title":"The Lancet"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0045","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/hep.21732","article-title":"The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end\u2010stage liver disease calculation","volume":"46","author":"Tripodi","year":"2007","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1572-0241.2006.00353.x","article-title":"Pathogenesis and treatment of Budd\u2013Chiari syndrome combined with portal vein thrombosis","volume":"101","author":"Murad","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0055","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1053\/jhep.2003.50232","article-title":"Portal cavernoma\u2010associated cholangiopathy: a clinical and MR cholangiography coupled with MR portography imaging study","volume":"37","author":"Condat","year":"2003","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0060","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4414\/smw.2005.11035","article-title":"Portal vein thrombosis (PVT): a study of 20 non\u2010cirrhotic cases","volume":"135","author":"Kocher","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0065","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/hep.510310307","article-title":"Cause of portal or hepatic venous thrombosis in adults: the role of multiple concurrent factors","volume":"31","author":"Denninger","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2036.2004.02301.x","article-title":"Review article: portal vein thrombosis \u2013 new insights into aetiology and management","volume":"21","author":"Webster","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0075","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1053\/jhep.2000.16597","article-title":"Recent portal or mesenteric venous thrombosis: increased recognition and frequent recanalization on anticoagulant therapy","volume":"32","author":"Condat","year":"2000","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0080","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1002\/lt.20869","article-title":"The role of TIPS for portal vein patency in liver transplant patients with portal vein thrombosis","volume":"12","author":"Bauer","year":"2006","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0085","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1053\/gast.2001.21209","article-title":"Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapy","volume":"120","author":"Condat","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0090","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.cgh.2006.09.030","article-title":"Chronic mesenteric venous thrombosis: evaluation and determinants of survival during long\u2010term follow\u2010up","volume":"5","author":"Orr","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0095","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0100","first-page":"1232","article-title":"Role of thrombosis in the pathogenesis of congestive hepatic fibrosis (cardiac cirrhosis)","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0105","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-127-4-199708150-00005","article-title":"Thrombopoietin levels in patients with cirrhosis before and after orthotopic liver transplantation","volume":"127","author":"Martin","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0110","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/00054725-200608000-00009","article-title":"Close association between activated platelets and neutrophils in the active phase of ulcerative colitis in humans","volume":"12","author":"Kayo","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0115","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/hep.20166","article-title":"Factor V Leiden as a risk factor for cirrhosis in chronic hepatitis C","volume":"39","author":"Poujol\u2010Robert","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0120","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gut.52.8.1206","article-title":"Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection","volume":"52","author":"Wright","year":"2003","journal-title":"Gut"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0125","first-page":"534","article-title":"The factor V Leiden mutation accelerates disease progression in a mouse model of hepatic fibrosis induced by chronic carbon tetrachloride exposure","volume":"40S","author":"Anstee","year":"2004","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0130","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1055\/s-0037-1615623","article-title":"Pulmonary fibrosis is increased in mice carrying the factor V Leiden mutation following bleomycin injury","volume":"85","author":"Xu","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0135","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/archinte.1991.00400050081016","article-title":"A population\u2010based perspective of the hospital incidence and case\u2010fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study","volume":"151","author":"Anderson","year":"1991","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0140","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1378\/chest.121.3.802","article-title":"Estimated incidence of acute pulmonary embolism in a community\/teaching general hospital","volume":"121","author":"Stein","year":"2002","journal-title":"Chest"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0145","first-page":"229","article-title":"Haemostasis unbalance in Pugh\u2010scored liver cirrhosis: characteristic changes of plasma levels of protein C versus protein S","volume":"23","author":"De Caterina","year":"1993","journal-title":"Haemostasis"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0150","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0049-3848(95)91614-Q","article-title":"Hemostasis activation in patients with liver cirrhosis","volume":"77","author":"Vukovich","year":"1995","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0155","first-page":"106","article-title":"Protein C deficiency in liver disease","volume":"20","author":"Walker","year":"1990","journal-title":"Ann Clin Lab Sci"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0160","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0049-3848(88)90073-4","article-title":"Immunological and functional determination of the protease inhibitors, protein C and antithrombin III, in liver cirrhosis and in neoplasia","volume":"52","author":"Zurborn","year":"1988","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0165","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1136\/bmj.309.6949.239","article-title":"Relation between lupus anticoagulant and splanchnic venous thrombosis in cirrhosis of the liver","volume":"309","author":"Violi","year":"1994","journal-title":"BMJ"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0170","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/hep.510230201","article-title":"Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome","volume":"23","author":"Prieto","year":"1996","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0175","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2036.2006.02730.x","article-title":"The efficacy and safety of epsilon\u2010aminocaproic acid treatment in patients with cirrhosis and hyperfibrinolysis","volume":"23","author":"Gunawan","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/hep.1840170115","article-title":"Hyperfibrinolysis resulting from clotting activation in patients with different degrees of cirrhosis. The CALC Group. Coagulation abnormalities in liver cirrhosis","volume":"17","author":"Violi","year":"1993","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0185","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0016-5085(95)90342-9","article-title":"Association between low\u2010grade disseminated intravascular coagulation and endotoxemia in patients with liver cirrhosis","volume":"109","author":"Violi","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0190","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1159\/000187859","article-title":"Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump\u2010driven extracorporeal circuits in patients with combined acute renal and hepatic failure","volume":"66","author":"Davenport","year":"1994","journal-title":"Nephron"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0195","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1046\/j.1523-1755.1999.00444.x","article-title":"Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding","volume":"55","author":"Palsson","year":"1999","journal-title":"Kidney Int"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0200","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/cc4985","article-title":"Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute\u2010on\u2010chronic alcoholic liver failure","volume":"10","author":"Laleman","year":"2006","journal-title":"Crit Care"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0205","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1016\/j.transproceed.2006.08.052","article-title":"Treatment of refractory cholestatic pruritus with molecular adsorbent recirculating system (MARS)","volume":"38","author":"Montero","year":"2006","journal-title":"Transplant Proc"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0210","doi-asserted-by":"crossref","first-page":"c211","DOI":"10.1159\/000088177","article-title":"Regional citrate anticoagulation in continuous hemodialysis \u2013 acid\u2010base and electrolyte balance at an increased dose of dialysis","volume":"101","author":"Morgera","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0215","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1183\/09031936.04.00010904","article-title":"Pulmonary\u2010hepatic vascular disorders (PHD)","volume":"24","author":"Rodriguez\u2010Roisin","year":"2004","journal-title":"Eur Respir J"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0220","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/hep.20658","article-title":"Natural history of hepatopulmonary syndrome: impact of liver transplantation","volume":"41","author":"Swanson","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0225","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/lt.20459","article-title":"Hemodynamics and survival of patients with portopulmonary hypertension","volume":"11","author":"Kawut","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0230","doi-asserted-by":"crossref","first-page":"S138","DOI":"10.1097\/01.mcg.0000155570.19340.61","article-title":"Mechanisms of pulmonary vascular complications of liver disease: hepatopulmonary syndrome","volume":"39","author":"Fallon","year":"2005","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0235","first-page":"91","article-title":"Portal axis thrombosis with spontaneous portocaval shunt and cor pulmonale","volume":"52","author":"Mantz","year":"1951","journal-title":"Arch Pathol"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/01.CIR.0000102381.57477.50","article-title":"Endothelial dysfunction in pulmonary hypertension","volume":"109","author":"Budhiraja","year":"2004","journal-title":"Circulation"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0245","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1055\/s-2004-823104","article-title":"The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four\u2010step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis","volume":"24","author":"Wanless","year":"2004","journal-title":"Semin Liver Dis"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0250","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.3748\/wjg.v11.i37.5834","article-title":"Association between thrombotic risk factors and extent of fibrosis in patients with non\u2010alcoholic fatty liver diseases","volume":"11","author":"Assy","year":"2005","journal-title":"World J Gastroenterol"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0255","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/hep.20781","article-title":"Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease","volume":"42","author":"Villanova","year":"2005","journal-title":"Hepatology"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0260","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1055\/s-0037-1613379","article-title":"Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use","volume":"89","author":"Abdollahi","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0265","doi-asserted-by":"crossref","first-page":"25J","DOI":"10.1016\/S0002-9149(99)00354-9","article-title":"Vascular reactivity","volume":"84","author":"Baron","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0270","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s001250051184","article-title":"Insulin\u2010mediated vasodilation: why one\u2019s physiology could be the other\u2019s pharmacology","volume":"42","author":"Steinberg","year":"1999","journal-title":"Diabetologia"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0275","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1365-2362.1990.tb02264.x","article-title":"Evidence for abnormal platelet glycoprotein expression in diabetes mellitus","volume":"20","author":"Tschoepe","year":"1990","journal-title":"Eur J Clin Invest"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0280","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.coph.2004.10.003","article-title":"Hypercoagulability in the metabolic syndrome","volume":"5","author":"Nieuwdorp","year":"2005","journal-title":"Curr Opin Pharmacol"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0285","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.metabol.2004.02.004","article-title":"Low\u2010grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study","volume":"53","author":"Yudkin","year":"2004","journal-title":"Metabolism"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0290","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/oby.2000.33","article-title":"Fibrinogen, other putative markers of inflammation, and weight gain in middle\u2010aged adults \u2013 the ARIC study. Atherosclerosis risk in communities","volume":"8","author":"Duncan","year":"2000","journal-title":"Obes Res"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0295","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1038\/oby.2003.131","article-title":"Weight loss reduces tissue factor in morbidly obese patients","volume":"11","author":"Kopp","year":"2003","journal-title":"Obes Res"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0300","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/sj.ijo.0802778","article-title":"Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor\u20101","volume":"28","author":"Skurk","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0305","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1055\/s-0037-1615906","article-title":"Hemostatic gene expression and vascular disease in obesity: insights from studies of genetically obese mice","volume":"82","author":"Samad","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0310","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1172\/JCI118404","article-title":"Distribution and regulation of plasminogen activator inhibitor\u20101 in murine adipose tissue in vivo. Induction by tumor necrosis factor\u2010alpha and lipopolysaccharide","volume":"97","author":"Samad","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0315","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.2337\/diabetes.52.5.1248","article-title":"A novel role for CD36 in VLDL\u2010enhanced platelet activation","volume":"52","author":"Englyst","year":"2003","journal-title":"Diabetes"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0320","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1007\/s00125-004-1417-4","article-title":"Expression of fatty\u2010acid\u2010handling proteins in human adipose tissue in relation to obesity and insulin resistance","volume":"47","author":"Gertow","year":"2004","journal-title":"Diabetologia"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0325","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.diabres.2004.10.007","article-title":"A comparison of the effects of pioglitazone and rosiglitazone combined with glimepiride on prothrombotic state in type 2 diabetic patients with the metabolic syndrome","volume":"69","author":"Derosa","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1111\/j.1538-7836.2007.02772.x_bb0330","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1592\/phco.25.5.637.63587","article-title":"Antithrombotic effects of rosiglitazone\u2010metformin versus glimepiride\u2010metformin combination therapy in patients with type 2 diabetes mellitus and metabolic syndrome","volume":"25","author":"Derosa","year":"2005","journal-title":"Pharmacotherapy"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2007.02772.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622131697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622131697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2007.02772.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:45:37Z","timestamp":1761533137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622131697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":65,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S1538783622131697"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02772.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypercoagulation and thrombophilia in liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2007.02772.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}